1/17/2022 | 3002150000 | MEDICINE TREATMENT KIT RAVULIZUMAB, SOLUTION FOR SC 70 MG/ML, 3.5 ML IN CARTRIDGE WITH INJECTOR, EXPIRED 09/30/2022, SERIES 1001886, NO COMMERCIAL VALUE, NOT FOR RESALE OR RESALE | 34 | 270108.9 | Italy | UNKNOWN | CINEOS HEALTH RUS LLC |
1/18/2022 | 3002150000 | RETAIL MEDICINE FOR MEDICAL USE (VED 1H): SIMPONI (GOLIMUMAB) SOLUTION FOR SUBCUTANEOUS INTRODUCTION, 50 MG/0.5 ML (PEN) 0.5 ML X 1 (CARDBOARD PACK) - 6002 PACK, SERIES 21C1064 YEAR.YEAR.4 , GROSS WEIGHT | 620.21 | 3681403 | United States of America | MOSCOW RUSSIA | MSD PHARMASYUTICALS LLC |
1/12/2022 | 3002150000 | MEDICINAL FOR RETAIL SALE (VED, 5V): EKORAL (CYCLOSPORINE) CAPSULES, 100 MG (BLISTER) 10 X 5 (CARDBOARD PACK) - 2184 PU., SERIES 100028883, EXPIRED 09.2023, GROSS WEIGHT WITH PALLETS 20.40 | 362.54 | 85969.5 | Czechia | MOSCOW RUSSIA | TEVA LLC |
1/12/2022 | 3002150000 | Medicines for medical use for retail sale, (ZHHVLP, 5B): Capsules 25 mg (cyclosporine) 10 x 5 (cardboard box) - 8960 pack., Series 100029623 Got to 10.2023, gross weight with pallets 929.200 kg. | 689.92 | 88323.1 | Czechia | MOSCOW RUSSIA | TEVA LLC |
1/26/2022 | 3002150000 | MEDICINE SUPPLIED UNDER GOVERNMENT DECREE No. 441 OF 04/03/2020: ETESEVIMAB (ETESEVIMAB) SOLUTION FOR INFUSION 700 MG / 20 ML (BOTTLE) X 1 (CARDBOARD PACK) - 22215 UP. , SERIES D437700A EXPIRED 12/2022 GROSS WEIGHT C | 1244.04 | 4720693.8 | Puerto Rico | LONG WORKING CITY | PHARMSTANDART JSC |
1/31/2022 | 3002150000 | SOLIRIS (ECULIZUMAB), 10 MG/ML, 30 ML (300 MG VIAL) CONCENTRATE FOR INFUSION, SERIES 1001746, EXPIRY 6/30/2023 - 52 VIALS, THE MEDICINE IS NEEDED TO RENDER MEDICAL CARE | 4.32 | 214816.3 | Ireland | Unknown | PAREXEL INTERNATIONAL RUS LLC |
1/26/2022 | 3002150000 | MEDICINE SUPPLIED UNDER GOVERNMENT DECREE No. 441 OF 04/03/2020: BAMLANIVIMAB (BAMLANIVIMAB) SOLUTION FOR INFUSION 700 MG / 20 ML (BOTTLE) X 1 (CARDBOARD PACK) -14000 UP. , SERIES S21D004A EXPIRY 10.2022 , GROSS WEIGHT | 728 | 8750003.8 | Italy | LONG WORKING CITY | PHARMSTANDART JSC |
1/31/2022 | 3002150000 | SAR408701, 5 MG/ML IV INfusion SOLUTION CONCENTRATE IN 25 ML VIAL, 46 VIALS TOTAL, SERIES IP026884, EXPIRY 5/2023, : | 3.86 | 10129.9 | Germany | Unknown | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
1/17/2022 | 3002150000 | MEDICINES FOR RETAIL: RESTASIS (CYCLOSPORINE) EYE DROPS 0.05% (BOTTLE) 0.4 ML X 30 (CARDBOARD PACK) - 4104 UP. SERIES T3932 IS EXPIRED UNTIL 08.2023 ACTIVE SUBSTANCE: CYCLOSPORINE. | 279 | 100874.9 | United States of America | MOSCOW RUSSIA | ALLERGAN CIS SARL LLC |
1/18/2022 | 3002150000 | RETAIL MEDICINES: FAZENRA (BENRALIZUMAB) SUBCUTANEOUS SOLUTION, 30 MG/ML (SYRINGE) 1.0 ML X 1 (CARDBOARD PACK) - 1393 PK, SERIES NN0121 EXPIRY 06.2024, GROSS WEIGHT WITH 5.106 PALLETS | 175.24 | 2200723 | United States of America | MOSCOW RUSSIA | ASTRAZENEKA PHARMACIES LLC |